Results 151 to 160 of about 114,420 (320)
Out of 274 lung transplant (LTx) patients, 89 (32%) developed invasive aspergillosis IA. Factors associated with IA were mycophenolate mofetil use, airway stenosis, Aspergillus cultured pre‐LTx, chronic lung allograft dysfunction (CLAD), and acute rejection. The role of nebulized amphotericin B and statins for prevention of IA remains unclear. ABSTRACT
Johanna P. van Gemert+7 more
wiley +1 more source
Use of POCtmPCR with noninvasive samples (NPS and sputum) in LTx recipients with viral LRTI are a viable alternative to invasive BAL sampling, ABSTRACT Background Respiratory tract infections (RTIs) are a leading cause of morbidity and mortality following lung transplantation (LTx).
Susanne Simon+4 more
wiley +1 more source
New Bronchoscopic Treatments for Lung Peripheral Lesions
Javier Flandes+2 more
doaj
Bronchoscopy in octogenarians [PDF]
Ariel Rokach+3 more
openaire +3 more sources
Respiratory Viruses at Time of Lung Transplant and the Relationship to Primary Graft Dysfunction
Primary graft dysfunction (PGD) is a form of severe and immediate post‐transplant lung injury that can lead to death. In our cohort of 229 patients undergoing lung transplantation with protocolized day 1 bronchoscopy specimens sent for respiratory viruses (RVs), RV+ status was not associated with an adjusted difference in the risk of PGD.
Laura van den Bosch+11 more
wiley +1 more source
A novel regimen of sulfamethoxazole/trimethoprim single strength one tablet twice weekly for Pneumocystis jiroveci Pneumonia (PJP) prophylaxis in lung transplant patients found no cases of PJP over an 8‐year period and may reduce the incidence of medication discontinuation due to adverse effects. ABSTRACT Background Pneumocystis jiroveci pneumonia (PJP)
Chloe Munroe+8 more
wiley +1 more source